Theta Research
  • Home
  • Graph
  • CompaniesPro
  • Pulse
  • Pricing
  • Shipped
  • Engine

For serious investors who think in systems.

partners@theta.md

Xiaohongshu · 26469493287

ProductAtlasCompaniesPulseEventsEnginePricing
CompanyAboutHow it worksChangelog
LegalTermsPrivacyRefunds

© 2026 theta.md

Theta Research provides research and analytics for informational purposes only. Nothing on this site is investment advice.

← Back to Events
UPCOMINGTier 1earnings-single

Oracle Q4 FY2026 Earnings — RPO Backlog + OCI Ramp vs $50B-Capex / Cloud-Margin Test

2026-06-10 → 2026-06-10·7 companies·12 predictions
?ORCLdirect?NVDAsupply-chain?AMDsupply-chain?MSFTcompetitive?CRWVcompetitive?NBIScompetitive—AMZNcompetitive

Scenario Comparison

Bull CaseS1
25%

RPO grows to ≥$600B (sequential backlog re-acceleration), OCI/IaaS growth holds ≥80% YoY, Q4 revenue ≥$19.3B and non-GAAP EPS ≥$2.00 (beat both). FY2027 revenue guidance raised above the prior ~$90B (toward $95B+) and/or a multi-year FY2028-30 cloud-revenue ramp framed explicitly. Cloud gross margin stable/up and capex framed as 'demand-backed' rather than speculative.

↑ 7↓ 07 companies
+ORCLstrong
+NVDAmoderate
+AMDmild
+CRWVstrong
+3 more
Base CaseS2
40%

Q4 revenue ~$19.0-19.3B and non-GAAP EPS ~$1.96-$2.00 (in-line to slight beat). RPO grows modestly to ~$560-595B (up, but backlog GROWTH RATE decelerates off the +325% YoY base). OCI growth ~70-80%. FY2027 ~$90B reaffirmed (NOT raised). Cloud gross margin roughly stable; capex reiterated near ~$50B.

↑ 0↓ 36 companies
−ORCLmoderate
−CRWVmoderate
−NBISmild
~NVDAmild
+2 more
Bear CaseS4
10%

Q4 revenue misses (<$18.9B) and/or non-GAAP EPS <$1.92, OR RPO declines/flatlines (a contract delay, downsizing, or OpenAI/Stargate timing slip surfaces), OR FY2027 guidance trimmed below ~$90B. Cloud gross margin falls toward/below ~60%. Credit/leverage commentary turns cautious.

↑ 0↓ 77 companies
−ORCLstrong
−CRWVstrong
−NBISstrong
−NVDAmoderate
+3 more

All Scenarios

5

Positioning Suggestions

→ PRE-EARNINGS: ORCL is richly valued (~28-30x FY27E consensus EPS into the print, a PREMIUM to the 22-25x 5yr avg) and trades ABOVE its $195 base-case fair value, near/above the $230 bull target. The thesis riskReward is UNFAVORABLE. Probability-weighted setup is asymmetrically negative for new money: a blowout is partly priced; an in-line is a fade.

→ If holding from below (the disciplined add zone was $120-130): consider trimming 25-50% into strength to lock the +40-58% re-rating; the easy money is made and the Q4 print is a two-sided catalyst at a stretched multiple.

→ DO NOT initiate aggressively at ~$235 ahead of the print. The base case ($195) implies double-digit downside even if the company executes in-line; the bull case ($230) is already near/breached.

→ Options: the ~±11% implied move is rich. A long straddle is fairly priced but expensive; a defined-risk put spread (e.g. ~$210/$195) collects the rich IV with bear-case cushion. Avoid naked long calls into a 'priced-for-perfection' setup.

→ Watch-list / proxy reads: CRWV and NBIS are the high-beta AI-neocloud amplifiers (≈1.5-2x ORCL's AI-infra signal). Use them as the supercycle tell — a clean OCI/RPO beat lifts them more than ORCL; an OCI decel/margin-pressure print hits them harder.

→ If Scenario 3-4 (OCI decel / miss / RPO crack) plays out: defer adds — let the multiple compress toward the $180-205 zone and re-anchor on the actual RPO-conversion trend before catching the move. The #1 invalidation signal is RPO conversion <8% for two consecutive quarters.

→ If Scenario 1 + 5 (blowout + new mega-contract) co-occur: that is the one combination that justifies HOLDING through the print and adding only on confirmed RPO diversification away from single-customer concentration.

→ Post-print, run /complete-research to reset ORCL scenarios/weights against the actual FY2026 close + FY2027 guidance before any conviction-label change (the thesis explicitly defers the re-underwrite to post-2026-06-11).

Predictions

12
○

Oracle Q4 FY2026 non-GAAP EPS lands within the $1.92-$2.06 range (i.e., near the ~$1.96 consensus / $1.96-$2.00 guide, no large miss or blowout on the EPS line).

80%P1
○

Q4 FY2026 total revenue is ≥ $19.0B (i.e., meets the lower end of the ~$19.1B consensus / +19-21% USD guide).

75%P2

If <$18.9B → revenue miss; expect a sharp gap-down toward the $195-205 zone; do not add until RPO-conversion trend confirmed.

○

Total RPO grows sequentially vs the $553B reported at Q3 FY2026 (i.e., backlog still expanding, not declining).

70%P3

If RPO declines/flatlines → bear-mechanism (paper-backlog/concentration) activates; expect 15%+ drawdown and re-open path toward $115 bear target.

○

Total RPO reaches ≥ $600B (sequential backlog re-acceleration — the bull trigger).

40%P4

If ≥$600B → strongest single-line bull confirmation; supports a move toward/above the $230 thesis bull target.

○

OCI/IaaS revenue growth prints ≥ 75% YoY (vs 84% at Q3 — i.e., the hyperscaler-growth trajectory does NOT sharply decelerate).

55%P5

If <70% → deceleration narrative activates; multiple-compression risk toward $195-205 even on in-line revenue.

○

Total cloud (IaaS+SaaS) revenue grows ≥ 46% YoY in USD (i.e., meets the lower bound of Oracle's +46-50% USD Q4 cloud guide).

70%P6
○

Management RAISES the FY2027 total-revenue outlook above the prior ~$90B target (vs merely reaffirming it).

45%P7

If raised → bull catalyst, supports near-bull multiple; if only reaffirmed at ~$235 spot → sell-the-news fade risk dominates.

○

FY2027 capex guidance is held in the ~$45-55B range (i.e., NOT a dramatic step-up beyond the ~$50B FY2026 level).

50%P8

If guided materially >$55B with deepening negative FCF and no margin offset → 'growth-at-any-cost' de-rate risk.

○

Oracle discloses a NEW named hyperscale-AI or large multicloud contract beyond OpenAI/Stargate that diversifies the RPO base (Scenario 5).

25%P9

If announced → attacks the #1 (concentration) bear pillar; expect 5-10% upside on top of base reaction; constructive add signal.

○

ORCL stock closes the first session after the print (T+1) BELOW its pre-print spot (~$235 working anchor) — i.e., the stretched setup produces a sell-the-news / no-net-upside reaction.

50%P10

Embeds the unfavorable risk/reward read at ~28-30x FY27E into a ±11% implied move; a 'good-but-priced-in' print fades.

○

ORCL moves at least ±8% on the first session after the print (i.e., the realized move is comparable to the ~±11% options-implied move — a binary, not a muted, reaction).

55%P11
○

CRWV (AI-neocloud high-beta proxy) closes T+1 in the SAME direction as ORCL's post-print move (positive sympathy on a beat, negative on a miss/decel).

60%P12

Use CRWV/NBIS as the supercycle tell — they typically amplify ORCL's AI-infra signal 1.5-2x.

Key Questions

  1. RPO: does the backlog grow to ≥$600B (re-acceleration) or does the GROWTH RATE inflect off the +325%-YoY / $553B Q3 base? This is the single most important read — a backlog stall punctures the 'contracted demand de-risks $50B capex' narrative even on an in-line P&L.
  2. OCI/IaaS growth rate vs the 84% YoY Q3 print: holding ≥80% = hyperscaler trajectory intact; <70% = deceleration narrative activates.
  3. Cloud GROSS MARGIN trajectory: is the 70%→64% compression stabilizing, or does data-center depreciation keep outrunning utilization? Segment cloud GM held >30% in Q3 — any further erosion is the core bear mechanism.
  4. FY2027 revenue guidance: is the ~$90B (+~34% YoY) target RAISED (toward $95B+, the bull trigger) or merely reaffirmed (the in-line/fade setup)? Mgmt previously said 'can meet and likely exceed.'
  5. Capex guidance for FY2027: held near ~$50B, or stepped up materially? A step-up WITH deepening negative FCF and no margin offset is the 'growth-at-any-cost' red flag.
  6. RPO near-term conversion rate (only ~10% converts within 12 months): does the conversion improve toward 12-15%, or does the backlog stay back-loaded — confirming the 'paper RPO' skepticism?
  7. Customer concentration: any NEW named hyperscale-AI or multicloud contract beyond OpenAI/Stargate that diversifies the backlog (Scenario 5)?
  8. OpenAI/Stargate ramp pacing: any update to the Abilene 1.2GW-live / remaining-3.8GW-by-when timeline, or to the OpenAI $600B-through-2030 rent-shift?
  9. FCF / balance sheet: net debt >$100B, 9M FY26 FCF ~-$21.8B — any commentary on a path to FCF inflection or credit-outlook defense?
  10. Q4 non-GAAP EPS vs the $1.96 consensus / $1.96-$2.00 guide: in-line is priced; the asymmetry is in revenue mix + guide, not the EPS headline.

Monitoring Checklist

0/12 checked